Zanamivir Powder
NDC Package 63379-028-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Zanamivir powders is zanamivir is used to treat symptoms caused by the flu virus (influenza) if you have had symptoms for 2 days or less. This formulation utilizes a powder delivery system. Marketed by Glaxo Operations Uk Ltd, this product is identified by NDC 63379-028.

Identification & Billing

NDC Package Code
63379-028-00
Package Description
12.25 kg in 1 DRUM
Product Code
63379-028
11-Digit Billing Format
63379002800

Clinical Specifications

Proprietary Name
Zanamivir
Non-Proprietary Name
Zanamivir
Substance Name
Zanamivir
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
ZANAMIVIR 1 kg/kg
Usage Information
Zanamivir is used to treat symptoms caused by the flu virus (influenza) if you have had symptoms for 2 days or less. It helps lessen symptoms (such as stuffy nose, cough, sore throat, fever/chills, headache, body aches, tiredness) and shortens the recovery time by about 1 to 2 days. Zanamivir may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. If you have the flu, zanamivir does not reduce the risk of giving the flu to others.

Regulatory & Marketing

Labeler Name
Glaxo Operations Uk Ltd
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
06-30-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63379-028-00 identifies a specific commercial package of 12.25 kg in 1 drum of Zanamivir (UNFINISHED drug), a bulk ingredient labeled by Glaxo Operations Uk Ltd. This powder is formulated for use and contains zanamivir as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glaxo Operations Uk Ltd on June 30, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Zanamivir is used to treat symptoms caused by the flu virus (influenza) if you have had symptoms for 2 days or less. It helps lessen symptoms (such as stuffy nose, cough, sore throat, fever/chills, headache, body aches, tiredness) and shortens the recovery time by about 1 to 2 days. Zanamivir may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. If you have the flu, zanamivir does not reduce the risk of giving the flu to others.

How is this Glaxo Operations Uk Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63379002800. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63379-028-00
11-Digit CMS (5-4-2)
63379-0028-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.